Moleculin Biotech posts September 2025 investor presentation; no material news disclosed

Moleculin Biotech, Inc.

Filed under Item 7.01 Regulation FD; presentation furnished as Exhibit 99.1.
Presentation posted on company website; no specific financial data or guidance provided.
No earnings, M&A, leadership, or other material events reported in filing.
Confidence low due to lack of substantive content in exhibit.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.